Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
80 | Pharmacy Times | trade journal | 0.100 Q4 | 8 | 91 | 549 | 496 | 5 | 234 | 0.01 | 5.45 | |
79 | Drug Topics | journal | 0.101 Q4 | 8 | 133 | 508 | 11 | 8 | 42 | 0.02 | 0.08 | |
78 | National Toxicology Program technical report series | journal | 0.114 | 22 | 3 | 7 | 0 | 7 | 7 | 0.00 | 0.00 | |
77 | Adverse Drug Reaction Bulletin | journal | 0.124 Q4 | 8 | 6 | 18 | 185 | 8 | 17 | 0.58 | 30.83 | |
76 | U.S. Pharmacist | trade journal | 0.130 Q4 | 12 | 117 | 377 | 1193 | 78 | 246 | 0.18 | 10.20 | |
75 | Pharmaceutical Chemistry Journal | journal | 0.188 Q4 | 39 | 214 | 600 | 5386 | 469 | 598 | 0.86 | 25.17 | |
74 | Journal of Experimental Therapeutics and Oncology | journal | 0.230 Q4 | 40 | 0 | 57 | 0 | 37 | 56 | 0.18 | 0.00 | |
73 | Hospital Pharmacy | journal | 0.253 Q4 | 28 | 128 | 191 | 2723 | 201 | 157 | 1.16 | 21.27 | |
72 | Medical Letter on Drugs and Therapeutics | journal | 0.254 Q4 | 22 | 114 | 311 | 806 | 171 | 207 | 0.71 | 7.07 | |
71 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.256 Q3 | 34 | 26 | 101 | 856 | 133 | 101 | 1.19 | 32.92 | |
70 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.267 Q3 | 29 | 7 | 23 | 645 | 69 | 7 | 3.18 | 92.14 | |
69 | Natural Product Communications | journal | 0.270 Q3 | 63 | 232 | 1053 | 9960 | 1493 | 1035 | 1.49 | 42.93 | |
68 | Clinical Neuropharmacology | journal | 0.334 Q3 | 85 | 64 | 163 | 1510 | 245 | 149 | 1.42 | 23.59 | |
67 | International Journal of Medicinal Mushrooms | journal | 0.376 Q3 | 41 | 99 | 314 | 2573 | 565 | 311 | 1.70 | 25.99 | |
66 | Chirality | journal | 0.397 Q3 | 83 | 77 | 363 | 3389 | 832 | 360 | 2.05 | 44.01 | |
65 | Drug and Chemical Toxicology | journal | 0.402 Q3 | 54 | 76 | 229 | 3452 | 635 | 229 | 2.72 | 45.42 | |
64 | American Journal of Therapeutics | journal | 0.406 Q3 | 69 | 172 | 528 | 3105 | 557 | 197 | 1.21 | 18.05 | |
63 | Current Cardiovascular Risk Reports | journal | 0.424 Q3 | 34 | 22 | 94 | 1361 | 77 | 94 | 0.94 | 61.86 | |
62 | Journal of the American Pharmacists Association : JAPhA | journal | 0.429 Q3 | 73 | 260 | 620 | 7092 | 942 | 511 | 1.45 | 27.28 | |
61 | Journal of AOAC International | journal | 0.457 Q3 | 100 | 280 | 580 | 8006 | 1166 | 551 | 1.91 | 28.59 | |
60 | Biologicals | journal | 0.460 Q3 | 66 | 45 | 212 | 1445 | 446 | 206 | 1.87 | 32.11 | |
59 | Anti-Cancer Drugs | journal | 0.463 Q3 | 102 | 143 | 409 | 4525 | 1012 | 408 | 2.34 | 31.64 | |
58 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.473 Q3 | 82 | 18 | 45 | 1794 | 182 | 45 | 3.65 | 99.67 | |
57 | American Journal of Health-System Pharmacy | journal | 0.483 Q3 | 107 | 413 | 1053 | 6221 | 1715 | 829 | 1.56 | 15.06 | |
56 | Food and Drug Law Journal | journal | 0.485 Q3 | 23 | 3 | 19 | 387 | 18 | 19 | 0.00 | 129.00 | |
55 | Current Therapeutic Research | journal | 0.487 Q3 | 46 | 35 | 88 | 1129 | 200 | 83 | 2.45 | 32.26 | |
54 | Steroids | journal | 0.501 Q3 | 114 | 95 | 443 | 4610 | 1306 | 437 | 2.79 | 48.53 | |
53 | Journal of Pharmacological and Toxicological Methods | journal | 0.507 Q3 | 83 | 49 | 212 | 2008 | 437 | 209 | 2.05 | 40.98 | |
52 | Therapeutic Drug Monitoring | journal | 0.555 Q3 | 102 | 106 | 336 | 4360 | 1018 | 305 | 2.95 | 41.13 | |
51 | Drug Development and Industrial Pharmacy | journal | 0.566 Q2 | 100 | 189 | 608 | 9400 | 2297 | 608 | 3.65 | 49.74 | |
50 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.579 Q2 | 70 | 59 | 159 | 2283 | 384 | 148 | 2.34 | 38.69 | |
49 | Neuropsychopharmacology Reports | journal | 0.579 Q2 | 22 | 65 | 129 | 2788 | 272 | 127 | 2.13 | 42.89 | |
48 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.580 Q2 | 72 | 80 | 273 | 2862 | 716 | 244 | 2.26 | 35.78 | |
47 | Behavioural Pharmacology | journal | 0.588 Q2 | 87 | 66 | 233 | 3895 | 586 | 226 | 2.21 | 59.02 | |
46 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.592 Q2 | 68 | 88 | 232 | 3314 | 818 | 225 | 3.73 | 37.66 | |
45 | Bulletin of Mathematical Biology | journal | 0.594 Q2 | 97 | 119 | 474 | 5321 | 925 | 463 | 1.94 | 44.71 | |
44 | Human gene therapy methods | journal | 0.599 Q2 | 38 | 0 | 49 | 0 | 174 | 49 | 4.42 | 0.00 | |
43 | Microbial Drug Resistance | journal | 0.648 Q2 | 78 | 204 | 574 | 8885 | 1869 | 570 | 2.94 | 43.55 | |
42 | Pharmaceutical Research | journal | 0.658 Q2 | 229 | 161 | 659 | 7751 | 2850 | 642 | 4.22 | 48.14 | |
41 | Journal of Biopharmaceutical Statistics | journal | 0.679 Q2 | 56 | 58 | 249 | 1352 | 276 | 237 | 1.12 | 23.31 | |
40 | Journal of Clinical Pharmacology | journal | 0.687 Q2 | 130 | 200 | 550 | 7850 | 1658 | 513 | 2.83 | 39.25 | |
39 | Reading Teacher | journal | 0.689 Q2 | 60 | 91 | 293 | 2666 | 371 | 245 | 1.18 | 29.30 | |
38 | Journal of Cardiovascular Pharmacology | journal | 0.694 Q2 | 109 | 214 | 370 | 10161 | 1123 | 344 | 3.00 | 47.48 | |
37 | Current Protocols in Pharmacology | journal | 0.698 Q2 | 39 | 0 | 39 | 0 | 125 | 39 | 3.96 | 0.00 | |
36 | Basic and Clinical Pharmacology and Toxicology | journal | 0.745 Q2 | 103 | 132 | 480 | 5332 | 1475 | 456 | 2.83 | 40.39 | |
35 | Contemporary Clinical Trials Communications | journal | 0.748 Q2 | 26 | 171 | 465 | 7193 | 972 | 454 | 1.70 | 42.06 | |
34 | Prostaglandins and Other Lipid Mediators | journal | 0.796 Q2 | 86 | 53 | 172 | 3157 | 572 | 170 | 3.60 | 59.57 | |
33 | Toxicology and Applied Pharmacology | journal | 0.811 Q2 | 189 | 262 | 945 | 14300 | 4206 | 938 | 4.26 | 54.58 | |
32 | Clinical Therapeutics | journal | 0.824 Q2 | 150 | 221 | 671 | 9084 | 1978 | 590 | 2.90 | 41.10 | |
31 | Experimental and Clinical Psychopharmacology | journal | 0.856 Q2 | 101 | 137 | 203 | 8607 | 603 | 200 | 3.12 | 62.82 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®